Fundraising Fox
Biotricity
OTC: BTCYRedwood City, US · Founded 2012 · Nevada corporation
Find your way into Biotricity
Sign up to see every warm intro you have to Biotricity
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biotricity team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.
Founders & leadership
Biotricity was founded in 2012 by Waqaas Al-Siddiq and Dr. Waqaas Alsiddiq, DBA.
WA
Waqaas Al-SiddiqCEO/Chairman
DW
Dr. Waqaas Alsiddiq, DBACo-founder · Chief Executive OfficerDr. Waqaas Alsiddiq is the founder of Biotricity, which develops FDA-cleared wearable cardiac and remote patient monitoring devices that capture ECG and vital-sign data and deliver reports to physicians.
Funding
SEC filings, press & company announcements$10.6M disclosed across 5 of 6 rounds · 2016–2024
- Undisclosed amountPIPE DealDec 2017Source ↗
▶$1MraisedApr 2024 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedApr 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chester WhiteDirector
- David A. RosaDirector
- John AyanoglouExecutive Officer
- Waqaas Al-SiddiqExecutive Officer, Director
- Ronald McClurgDirector
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $1M
- First sale
- Mar 2024
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.3MraisedAug 2020 · 24 investors · BiotechnologyRule 506(b)
▶$1.3MraisedAug 2020 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David RosaDirector
- Steve SalmonDirector
- Patricia KennedyDirector
- Waqaas Al-SiddiqExecutive Officer, Director
- John AyanoglouExecutive Officer
- Norman BettsDirector
- Offering amount
- $10M
- Amount sold
- $1.3M
- Minimum investment
- $100K
- Sales commissions
- $1.2M
- Placement agents
- Paulson Investment Company
- First sale
- Jul 2020
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$6MraisedDec 2019 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Waqaas Al-SiddiqExecutive Officer, Director
- John AyanoglouExecutive Officer
- Offering amount
- $10M
- Amount sold
- $6M
- First sale
- Dec 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.2MraisedMar 2017 · BiotechnologyRule 506(b)
▶$1.2MraisedMar 2017 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Waqaas Al-SiddiqExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $1.2M
- Minimum investment
- $50K
- Sales commissions
- $100K
- Placement agents
- Corinthian Partners LLC
- First sale
- Mar 2017
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
▶$1.1MraisedAug 2016 · 4 investors · Other Health CareRule 506(b)
▶$1.1MraisedAug 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Waqaas Al-SiddiqExecutive Officer, Director
- Norman M. Betts, M.D.Director
- David A. RosaDirector
- Offering amount
- $2.5M
- Amount sold
- $1.1M
- First sale
- Mar 2016
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
WHOOPWHOOP is a wearable health monitoring device that provides 24/7 tracking of sleep, strain, stress, and heart health metrics to help users optimize their fitness and wellness.
OuraOura Ring is a wearable smart ring that collects and analyzes 50+ personal health metrics to provide insights on sleep, fitness, and wellness for individual users.
BodyspecBodySpec provides DEXA scans that measure body fat percentage, lean muscle mass, visceral fat, and bone density, delivering a body composition report with an AI-powered dashboard and voice consultant. The company offers scans without a doctor's referral at 100+ locations across major US cities for consumers tracking their health and fitness.
WelltoryWelltory is a health technology company that helps individuals optimize their personal health outcomes through personalized science-based approaches, rather than generic wellness advice. The company employs health scientists, data researchers, and engineers focused on improving how people live their daily lives.
UltrahumanUltrahuman makes wearable and consumer health devices — including the Ring AIR smart ring, continuous glucose monitoring, red light therapy, sleep monitors, and blood biomarker testing — paired with an app for sleep, metabolic, and recovery tracking. Its products target consumers and athletes focused on preventive health, fitness, and longevity.
Companies working in the same space as Biotricity.
In the news
Frequently asked questions
- What does Biotricity do?
- Biotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.
- Who founded Biotricity?
- Biotricity was founded by Waqaas Al-Siddiq, Dr. Waqaas Alsiddiq, DBA in 2012.
- How much funding has Biotricity raised?
- Biotricity has disclosed $10.6M raised across 5 of its 6 known rounds.
- Where is Biotricity headquartered?
- Biotricity is headquartered in Redwood City, US.